Documentation
Core - Options 'Disable validation of ...' for SAML identity provider
Last updated: 2023-11-27 13:40
Real-world evidence of Adcetris in Belgium in Hodgkin Lymphoma patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36